CS567090A3 - Therapeutical agents - Google Patents

Therapeutical agents Download PDF

Info

Publication number
CS567090A3
CS567090A3 CS905670A CS567090A CS567090A3 CS 567090 A3 CS567090 A3 CS 567090A3 CS 905670 A CS905670 A CS 905670A CS 567090 A CS567090 A CS 567090A CS 567090 A3 CS567090 A3 CS 567090A3
Authority
CS
Czechoslovakia
Prior art keywords
pharmaceutically acceptable
formula
compounds
treatment
acceptable salts
Prior art date
Application number
CS905670A
Other languages
Czech (cs)
English (en)
Inventor
Brian Roy Holloway
Jacqueline Mary Jackson
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of CS567090A3 publication Critical patent/CS567090A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS905670A 1989-11-17 1990-11-16 Therapeutical agents CS567090A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898926083A GB8926083D0 (en) 1989-11-17 1989-11-17 Therapeutic agents

Publications (1)

Publication Number Publication Date
CS567090A3 true CS567090A3 (en) 1992-04-15

Family

ID=10666512

Family Applications (1)

Application Number Title Priority Date Filing Date
CS905670A CS567090A3 (en) 1989-11-17 1990-11-16 Therapeutical agents

Country Status (11)

Country Link
US (1) US5120766A (hu)
EP (1) EP0431763A3 (hu)
JP (1) JPH03193730A (hu)
KR (1) KR910009255A (hu)
AU (1) AU6594690A (hu)
CA (1) CA2030209A1 (hu)
CS (1) CS567090A3 (hu)
GB (2) GB8926083D0 (hu)
HU (1) HUT55630A (hu)
IE (1) IE903945A1 (hu)
ZA (1) ZA909185B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224740D0 (en) * 1992-11-26 1993-01-13 Ici Plc Therapeutic agents
CA2296104A1 (en) 1997-07-03 1999-01-14 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
KR20020069215A (ko) * 1999-12-16 2002-08-29 아사히 가세이 가부시키가이샤 신규한 치환기를 갖는 3환성 화합물
AU2003266165A1 (en) * 2002-09-13 2004-04-30 Hossein Dovlatabadi Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels
WO2006045008A2 (en) * 2004-10-19 2006-04-27 Cargill, Incorporated Meat having increased level of hdl

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
EP0233686A3 (en) * 1986-01-11 1989-05-03 Beecham Group Plc Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives

Also Published As

Publication number Publication date
ZA909185B (en) 1991-07-31
IE903945A1 (en) 1991-05-22
JPH03193730A (ja) 1991-08-23
EP0431763A2 (en) 1991-06-12
US5120766A (en) 1992-06-09
KR910009255A (ko) 1991-06-28
HU907129D0 (en) 1991-05-28
CA2030209A1 (en) 1991-05-18
HUT55630A (en) 1991-06-28
AU6594690A (en) 1991-05-23
EP0431763A3 (en) 1992-01-22
GB9023523D0 (en) 1990-12-12
GB8926083D0 (en) 1990-01-10

Similar Documents

Publication Publication Date Title
US5260305A (en) Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination
EP0324007B1 (en) A pharmaceutical composition containing s(+) ibuprofen substantially free of its r(-) antipode
EP0649657A1 (en) Pharmaceutical combinations containing a NSAID and an opioid analgesic
JP2000515526A (ja) Ｍｔｐ阻害剤と他のコレステロール低下薬を組合せて使用する、血清脂質レベルの降下方法
DE69121464T2 (de) Verfahren zur Verhütung, Stabilisierung oder Verursachung des Zurückgangs von Atherosklerose durch Anwendung einer Mischung von einem Cholesterol-vermindernden Arzneimittel mit einem ACE-Inhibitor
JP2004531468A5 (hu)
RU2225204C2 (ru) Комбинации рилузола с l-дофа для лечения болезни паркинсона
KR20020027463A (ko) 스핀고신-1-인산 수용체 아고니스트 또는스핀고신-1-인산을 유효 성분으로서 함유하는 선유화 억제제
EA039629B1 (ru) Фармацевтическая комбинация, содержащая селективный агонист рецептора s1p1
US20050187204A1 (en) Medicinal composition for lowering blood lipid level
EP1714648A1 (en) Combination drug
KR20010093845A (ko) 피브레이트와 세리바스타틴의 복합제제
NO324796B1 (no) Anvendelse av fosfolipidkomplekser ekstrahert fra Vitis vinifera ved fremstilling av antiaterosklerotiske midler.
EP0373507A1 (en) Combination of an HMG CoA reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CS567090A3 (en) Therapeutical agents
AU629533B2 (en) Improving toxicity profiles in chemotherapy
AU666992B2 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
JPH0699310B2 (ja) アセトアルデヒド解毒剤
KR100539066B1 (ko) 비정상적 지질대사-유래 질환치료에 유용한 스타틴과알카노일 ｌ-카르니틴 함유 약제 조성물
AU754719B2 (en) Method of treating neurodegenerative diseases
CA2492781A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocystein
MXPA04005557A (es) Metodo para tratar la osteoartritis.
US5244923A (en) Use of 2-(phenoxypropanolamino) ethoxphenoxy-acetic acid and its derivatives to inhibit gastrointestinal motility
EP0006845A1 (en) Pharmaceutical composition comprising a 5-aroyl-1-C1-5 alkyl-pyrrole-2-acetic acid compound and acetaminophen or acetylsalicylic acid
WO2008015763A1 (fr) Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire